Skip to main content

Find Clinical Trials

Home
Conditions
Solid Tumor

Clinical trial condition

Solid Tumor

Explore clinical trials studying Solid Tumor. Study availability and eligibility vary by location and protocol.

715 public trials 250 recruiting studies

Refine in advanced search Browse all conditions

Solid Tumor trial results

Recruiting

Immune Resistance Interrogation Study

NCT04243720

Conditions: Cancer, Immune Resistance, Metastatic Cancer, +6 more
Locations: Princess Margaret Cancer Centre Toronto, Ontario, Canada

View Trial Details

Recruiting

LANDscape MApping of Epitopes and T Cell Receptors for Selected Cancers

NCT04665388

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Princess Margaret Cancer Centre Toronto, Ontario, Canada

View Trial Details

Recruiting

Ex Vivo Expansion (ACT-X)

NCT07137312

Conditions: Healthy, Malignant Solid Neoplasm, Solid Tumor
Locations: Mayo Clinic in Florida Jacksonville, Florida, United States

View Trial Details

Recruiting

Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.

NCT07165132

Conditions: Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +24 more
Locations: Research Facility Iowa City, Iowa, United States

Research Facility Lexington, Kentucky, United States

Research Facility St Louis, Missouri, United States

Research Facility St Louis, Missouri, United States

View Trial Details

Recruiting

Prospective Analysis of Intestinal Microbiome and Autoimmune Panels as Predictors of Toxicity in ImmunOncology Patients

NCT04107311

Conditions: Solid Tumor
Locations: Princess Margaret Cancer Centre Toronto, Ontario, Canada

View Trial Details

Recruiting

Clinical Study of the Safety and Efficacy of Allogeneic TCR-enhanced Vδ2 T Cell in Patients With Malignant Tumors.

NCT07570563

Conditions: Hematologic Diseases, Hematologic Malignancy, Hematologic Neoplasms, +4 more
Locations: Biotherapeutic Department of Chinsese PLA Gereral Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

PET [89Zr]DFO-starPEG in Solid Tumors

NCT06894745

Conditions: Soft Tissue Lesion, Solid Carcinoma, Solid Tumor
Locations: University of California, San Francisco San Francisco, California, United States

View Trial Details

Recruiting

To Evaluate IAH0968 in Combination With CAPEOX in HER2-positive Gastric Cancer

NCT06504732

Conditions: Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +6 more
Locations: Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China

The First Hospital of China Medical University Shenyang, Liaoning, China

View Trial Details

Recruiting

A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types

NCT04300556

Conditions: Adenocarcinoma, Adnexal Diseases, Breast Diseases, +33 more
Locations: ACRC/Arizona Clinical Research Center, Inc Tucson, Arizona, United States

Universty of Arkansas for Medical Sciences Little Rock, Arkansas, United States

Stanford Women's Cancer Center Palo Alto, California, United States

University of Miami Coral Gables, Florida, United States

View all 58 locations

View Trial Details

Recruiting

Let's Get REAL: Family Health Communication Tool in Pediatric Stem Cell Transplant and Cellular Therapy

NCT06689800

Conditions: Anemia, Anemia, Aplastic, Anemia, Hemolytic, +22 more
Locations: Washington University School of Medicine St Louis, Missouri, United States

View Trial Details